04:33 PM EDT, 08/29/2024 (MT Newswires) -- Christopher R. Fenimore, Senior Vice President, Finance & CFO, on August 28, 2024, sold 5,680 shares in Regeneron Pharmaceuticals ( REGN ) for $6,846,262. Following the Form 4 filing with the SEC, Fenimore has control over a total of 18,742 shares of the company, with 15,305 shares held directly and 3,437 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/872589/000188385024000045/xslF345X05/edgardoc.xml